Market Overview

UPDATE: Citigroup Downgrades Comerica to Sell on Valuation, Interest Rate Exposure

Share:
Related CMA
Benzinga's M&A Chatter for Tuesday April 26, 2016
CLSA's Mike Mayo Talks Comerica's Annual Meeting: Management Is 'Finally Listening'
Medtronic names new finance chief (Seeking Alpha)

Citigroup downgraded Comerica (NYSE: CMA) from Neutral to Sell and raised the price target from $28.00 to $31.00.

Citigroup commented, "We view CMA as an above average bank but, at its current valuation, a bad stock. … Importantly, since the vast majority of CMA's loans price off of the very short-end of the yield curve, CMA really needs short rates to move up in order for its earnings to materially move up. … CMA is pricing in a '14 NIM ~28 bps and ~40 bps above our estimate and the consensus estimate, respectively. In order for that to happen, our model suggests that LIBOR in '14 would have to average ~110 bps versus its current ~29 bps and the implied forward rate of ~48 bps. That scenario would likely require at least a few near-term Fed rate hikes. As such, our sense is that the marginal buyer of CMA at its current valuation will be disappointed."

Comerica closed at $35.32 on Thursday.

Latest Ratings for CMA

DateFirmActionFromTo
Apr 2016Bank of AmericaUpgradesUnderperformNeutral
Apr 2016JP MorganMaintainsNeutral
Apr 2016BarclaysMaintainsUnderweight

View More Analyst Ratings for CMA
View the Latest Analyst Ratings

Posted-In: CitigroupAnalyst Color Price Target Analyst Ratings

 

Related Articles (CMA)

View Comments and Join the Discussion!